Exact Mass: 400.23802320000004
Exact Mass Matches: 400.23802320000004
Found 133 metabolites which its exact mass value is equals to given mass value 400.23802320000004
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
5alpha-Pregnan-3beta,20beta-diol 3-sulfate
C21H36O5S (400.22833260000004)
5alpha-Pregnan-3beta,20beta-diol 3-sulfate, also known as 5α-pregnan-3β,20β-diol sulfate, belongs to the class of organic compounds known as sulfated steroids. These are sterol lipids containing a sulfate group attached to the steroid skeleton. 5alpha-Pregnan-3beta,20beta-diol 3-sulfate has been identified in the human placenta (PMID: 32033212).
5alpha-Pregnan-3beta,20beta-diol 20-sulfate
C21H36O5S (400.22833260000004)
5alpha-Pregnan-3beta,20beta-diol 20-sulfate, also known as 5α-pregnan-3β,20β-diol sulfate, belongs to the class of organic compounds known as sulfated steroids. These are sterol lipids containing a sulfate group attached to the steroid skeleton. 5alpha-Pregnan-3beta,20beta-diol 20-sulfate has been identified in the human placenta (PMID: 32033212).
Nocloprost
C22H37ClO4 (400.23802320000004)
MG(5-iso PGF2VI/0:0/0:0)
MG(5-iso PGF2VI/0:0/0:0) is an oxidized monoacyglycerol (MG). Oxidized monoacyglycerols are glycerolipids in which the fatty acyl chain has undergone oxidation. As all oxidized lipids, oxidized monoacyglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with other lipids, monoacyglycerols can be substituted by different fatty acids, with varying lengths, saturation and degrees of oxidation attached at the C-1, C-2 and C-3 positions. Lipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with lipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized lipids is continually in flux, owing to lipid degradation and the continuous lipid remodeling that occurs while these molecules are in membranes. Oxidized MGs can be synthesized via three different routes. In one route, the oxidized MG is synthetized de novo following the same mechanisms as for MGs but incorporating an oxidized acyl chain (PMID: 33329396). An alternative is the transacylation of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the MG backbone, mainly through the action of LOX (PMID: 33329396).
MG(0:0/5-iso PGF2VI/0:0)
MG(0:0/5-iso PGF2VI/0:0) is an oxidized monoacyglycerol (MG). Oxidized monoacyglycerols are glycerolipids in which the fatty acyl chain has undergone oxidation. As all oxidized lipids, oxidized monoacyglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with other lipids, monoacyglycerols can be substituted by different fatty acids, with varying lengths, saturation and degrees of oxidation attached at the C-1, C-2 and C-3 positions. Lipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with lipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized lipids is continually in flux, owing to lipid degradation and the continuous lipid remodeling that occurs while these molecules are in membranes. Oxidized MGs can be synthesized via three different routes. In one route, the oxidized MG is synthetized de novo following the same mechanisms as for MGs but incorporating an oxidized acyl chain (PMID: 33329396). An alternative is the transacylation of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the MG backbone, mainly through the action of LOX (PMID: 33329396).
10-O-beta-D-glucopyranosideoplopanone|oplopanone-8-O-beta-D-glucopyranoside
1-O-isopropyl-6-O-(5,9-dimethyl-2,8-decadienoyl)-beta-D-glucopyranoside|citrusoside A
(4aS)-8t-Hydroxy-1t-sulfooxy-2c.10at.12at-trimethyl-(4arH.4btH.6acH.10bcH)-octadecahydro-chrysen|17abeta-Sulfooxy-17alpha-methyl-D-homo-5alpha-androstanol-(3beta)|Schwefelsaeure-mono-(3beta-hydroxy-17alpha-methyl-D-homo-5alpha-androstanyl-(17abeta)-ester)|sulfuric acid mono-(3beta-hydroxy-17alpha-methyl-D-homo-5alpha-androstanyl-(17abeta)-ester)
C21H36O5S (400.22833260000004)
1(R),4beta-dihydroxy-trans-eudesm-6-ene-1-O-beta-D-glucopyranoside
3beta,11-dihydroxy-drim-8(12)-en-11-O-beta-D-glucopyranoside|xianglinmaojueside A
3beta-[(beta-D-glucopyranosyl)oxy]eudesm-4(14)-en-11-ol
16-methoxy-1-propionyl-aspidospermidine-17,21-diol|16-methoxy-limaspermine|3-Methoxy-limaspermin
1alpha,6beta-dihydroxy-5,10-bis-epi-eudesm-4(15)-ene-6-O-beta-D-glucopyranoside|funingensin A
7-drimen-3beta-,11-diol 3-O-beta-D-glucopyranoside
3alpha-hydroxypatchoulol 3-O-beta-D-glucopyranoside
(2R*,5S*,7R*,10S*)-7-hydroperoxy-2-[(1-methyl-1-beta-D-fucopyranosyloxy)ethyl]-10-methyl-6-methylenespiro[4.5]-decane
1beta-hydroxy-3-oxo-4beta,5alpha,7alpha-H-eudesmane 11-O-alpha-L-rhamnopyranoside
2,7,11-trihydroxybisabola-1(15),9-diene 7-beta-D-fucopyranoside
2,7,10-trihydroxybisabola-1(15),11-diene 7-beta-D-fucopyranoside
(5S,6E)-5-beta-D-glucopyranosyloxy-3-hydroxy-3,7,11-trimethyldodeca-1,6,10-triene|amarantholidoside III
3beta,11-dihydroxy-drim-8(12)-en-3-O-beta-D-glucopyranoside|xianglinmaojueside B
1beta-(beta-D-glucopyranosyl)oxy-6alpha-hydroxyeudesman-4(15)-ene|1??-D-Glucopyranosyloxy-6??-hydroxyeudesman-4(15)-ene
1(R),4beta-dihydroxy-trans-eudesm-7-ene-1-O-beta-D-glucopyranoside|oplodiol 1-O-beta-D-glucopyranoside
11,14-dihydroxy-drim-8(12)-en-11-O-beta-D-glucopyranoside|xianglinmaojueside C
phenyl-acetic acid 9-hydroxymethyl-7-(6-oxo-piperidin-2-yl)-octahydro-quinolizin-2-yl ester
2-[5-[2-[2-[5-(2-hydroxybutyl)oxolan-2-yl]propanoyloxy]propyl]oxolan-2-yl]propanoic acid
2-[5-[2-[2-[5-(2-hydroxybutyl)oxolan-2-yl]propanoyloxy]propyl]oxolan-2-yl]propanoic acid [IIN-based on: CCMSLIB00000846078]
2-[5-[2-[2-[5-(2-hydroxybutyl)oxolan-2-yl]propanoyloxy]propyl]oxolan-2-yl]propanoic acid [IIN-based: Match]
Ala Ile Pro Thr
C18H32N4O6 (400.23217320000003)
Ala Ile Thr Pro
C18H32N4O6 (400.23217320000003)
Ala Leu Pro Thr
C18H32N4O6 (400.23217320000003)
Ala Leu Thr Pro
C18H32N4O6 (400.23217320000003)
Ala Pro Ile Thr
C18H32N4O6 (400.23217320000003)
Ala Pro Leu Thr
C18H32N4O6 (400.23217320000003)
Ala Pro Thr Ile
C18H32N4O6 (400.23217320000003)
Ala Pro Thr Leu
C18H32N4O6 (400.23217320000003)
Ala Thr Ile Pro
C18H32N4O6 (400.23217320000003)
Ala Thr Leu Pro
C18H32N4O6 (400.23217320000003)
Ala Thr Pro Ile
C18H32N4O6 (400.23217320000003)
Ala Thr Pro Leu
C18H32N4O6 (400.23217320000003)
Ile Ala Pro Thr
C18H32N4O6 (400.23217320000003)
Ile Ala Thr Pro
C18H32N4O6 (400.23217320000003)
Ile Pro Ala Thr
C18H32N4O6 (400.23217320000003)
Ile Pro Thr Ala
C18H32N4O6 (400.23217320000003)
Ile Thr Ala Pro
C18H32N4O6 (400.23217320000003)
Ile Thr Pro Ala
C18H32N4O6 (400.23217320000003)
Leu Ala Pro Thr
C18H32N4O6 (400.23217320000003)
Leu Ala Thr Pro
C18H32N4O6 (400.23217320000003)
Leu Pro Ala Thr
C18H32N4O6 (400.23217320000003)
Leu Pro Thr Ala
C18H32N4O6 (400.23217320000003)
Leu Thr Ala Pro
C18H32N4O6 (400.23217320000003)
Leu Thr Pro Ala
C18H32N4O6 (400.23217320000003)
Pro Ala Ile Thr
C18H32N4O6 (400.23217320000003)
Pro Ala Leu Thr
C18H32N4O6 (400.23217320000003)
Pro Ala Thr Ile
C18H32N4O6 (400.23217320000003)
Pro Ala Thr Leu
C18H32N4O6 (400.23217320000003)
Pro Ile Ala Thr
C18H32N4O6 (400.23217320000003)
Pro Ile Thr Ala
C18H32N4O6 (400.23217320000003)
Pro Leu Ala Thr
C18H32N4O6 (400.23217320000003)
Pro Leu Thr Ala
C18H32N4O6 (400.23217320000003)
Pro Ser Val Val
C18H32N4O6 (400.23217320000003)
Pro Thr Ala Ile
C18H32N4O6 (400.23217320000003)
Pro Thr Ala Leu
C18H32N4O6 (400.23217320000003)
Pro Thr Ile Ala
C18H32N4O6 (400.23217320000003)
Pro Thr Leu Ala
C18H32N4O6 (400.23217320000003)
Pro Val Ser Val
C18H32N4O6 (400.23217320000003)
Pro Val Val Ser
C18H32N4O6 (400.23217320000003)
Ser Pro Val Val
C18H32N4O6 (400.23217320000003)
Ser Val Pro Val
C18H32N4O6 (400.23217320000003)
Ser Val Val Pro
C18H32N4O6 (400.23217320000003)
Thr Ala Ile Pro
C18H32N4O6 (400.23217320000003)
Thr Ala Leu Pro
C18H32N4O6 (400.23217320000003)
Thr Ala Pro Ile
C18H32N4O6 (400.23217320000003)
Thr Ala Pro Leu
C18H32N4O6 (400.23217320000003)
Thr Ile Ala Pro
C18H32N4O6 (400.23217320000003)
Thr Ile Pro Ala
C18H32N4O6 (400.23217320000003)
Thr Leu Ala Pro
C18H32N4O6 (400.23217320000003)
Thr Leu Pro Ala
C18H32N4O6 (400.23217320000003)
Thr Pro Ala Ile
C18H32N4O6 (400.23217320000003)
Thr Pro Ala Leu
C18H32N4O6 (400.23217320000003)
Thr Pro Ile Ala
C18H32N4O6 (400.23217320000003)
Thr Pro Leu Ala
C18H32N4O6 (400.23217320000003)
Val Pro Ser Val
C18H32N4O6 (400.23217320000003)
Val Pro Val Ser
C18H32N4O6 (400.23217320000003)
Val Ser Pro Val
C18H32N4O6 (400.23217320000003)
Val Ser Val Pro
C18H32N4O6 (400.23217320000003)
Val Val Pro Ser
C18H32N4O6 (400.23217320000003)
Val Val Ser Pro
C18H32N4O6 (400.23217320000003)
5alpha-Pregnan-3beta,20beta-diol 20-sulfate
C21H36O5S (400.22833260000004)
Amantadine sulfate
C20H36N2O4S (400.23956560000005)
D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents D000890 - Anti-Infective Agents > D000998 - Antiviral Agents C254 - Anti-Infective Agent > C281 - Antiviral Agent C93038 - Cation Channel Blocker
Ala-Leu-Thr-Pro
C18H32N4O6 (400.23217320000003)
A tetrapeptide composed of L-alanine, L-leucine, L-threonine, and L-proline units joined in sequence.
1-cyclopentyl-1-[2-(5,6-dimethyl-1H-benzimidazol-2-yl)ethyl]-3-(2-oxolanylmethyl)thiourea
2,4-dioxo-3-pentyl-N-[3-(1-piperidinyl)propyl]-1H-quinazoline-7-carboxamide
C22H32N4O3 (400.24742819999994)
rel-(2R,5S,7R,10S)-7-Hydroperoxy-2-[(1-methyl-1-beta-D-fucopyranosyloxy)ethyl]-10-methyl-6-methylenespiro[4.5]-decane
A natural product found in Carthamus oxyacantha.
2-(dimethylamino)-1-[(1R)-1-(hydroxymethyl)-7-methoxy-2-methyl-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]ethanone
C22H32N4O3 (400.24742819999994)
2-(dimethylamino)-1-[(1S)-1-(hydroxymethyl)-7-methoxy-2-methyl-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]ethanone
C22H32N4O3 (400.24742819999994)